MultiplAI leverages genomics and AI to provide universal remote screening for cardiovascular diseases among other complex diseases. We use a liquid biopsy of whole blood based on RNA sequencing and deep learning looking at all biomarkers in the blood, thus creating a superbiomarker to detect diseases earlier. Our test can be used in continuous testing both for preventative screening and post-treatment monitoring. Given that it requires only a simple blood sample, it can be administered remotely, anywhere, and costs a fraction of existing diagnostic methods.
Location: United Kingdom, England, London
Employees: 11-50
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | First In V... | firstinven... |
Mentions in press and media 4
| Date | Title | Description |
| 30.09.2024 | HEARTX CARDIOVASCULAR ACCELERATOR ANNOUNCES FOUR STARTUP COMPANIES SELECTED FOR THE 2024 PROGRAM | HeartX, powered by HealthTech Arkansas and MedAxiom — along with numerous leading cardiology practices in Arkansas and around the country — has selected four startup healthcare companies to participate in its 2024 accelerator program. Heart... |
| 04.11.2021 | 10 new data-driven health companies selected for KQ Labs accelerator programme | 10 innovative start-up companies working at the interface of biomedical and data science are to receive personalised mentoring and coaching as part of the KQ Labs accelerator programme, run by the Francis Crick Institute and funded by the m... |
| 12.02.2021 | StartUPDATES: New developments from healthcare startups | Turing, based in Palo Alto, California, announced its second virtual remote work conference, Turing Boundaryless: #BuildfromAnywhere, slated for February 18th and featuring executives from major healthcare companies such as Abbott Laborator... |
| - | StartUPDATES: New developments from healthcare startups | Turing, based in Palo Alto, California, announced its second virtual remote work conference, Turing Boundaryless: #BuildfromAnywhere, slated for February 18th and featuring executives from major healthcare companies such as Abbott Laborator... |